Stock·NYSE·Industrials
Allegion (ALLE)
- Market cap
- $13.31B
- P/E
- 20.52
- Dividend yield
- 1.38%
- Street target
- $170.00median of 11 analysts
- 52-week range
- $125.00 $183.11
The short version
Where ALLE stands today, in four lines, and what CleaRank Financial AI makes of it.
ALLE at a glance
Allegion (ALLE): Buy, 70/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($149.88 and $156.60).
- Earnings ALLE beat estimates in 6 of its last 7 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $5.2M and bought $591K over the last 18 months.
- Valuation P/E of 20.5 against 34.0 for the Industrials sector: a discount to peers (-40%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Allegion (ALLE) Buy, with a model score of 70/100.
The trend lifts the score most: the price is 4.44% above its 200-day average, and the 50-day average is 4.49% above the 200-day. Momentum holds it back most: the MACD line is negative. The 50-day average stands at $156.60 and the 200-day at $149.88. Over the past year the price fell 11.81%.
Only on CleaRank
Figures we compute ourselves from ALLE's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $156.54 is 0.0% below the 50-day simple moving average of $156.60.Price above its 200-day average ›
The price is 4.4% above the 200-day simple moving average of $149.88.50-day average above the 200-day ›
The 50-day average ($156.60) is 4.5% above the 200-day average ($149.88), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 54% of its 52-week range, between $125.00 and $183.11.
ALLE share price
Pick a period: each tab shows how far ALLE has moved over it, to the last close.
Today's trading
Where ALLE sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 20.52 is 39.7% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 3.10 is 22.4% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $658.6M on revenue of $4.3B, a net margin of 15.4%.Beat estimates in most recent reports ›
ALLE beat the EPS estimate in 6 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.38%, or $2.16 a share a year.
Key statistics
The headline figures for ALLE.
As of October 17, 2026, ALLE trades at $156.54, with a market value of $13.31B, a P/E ratio of 20.52 and a dividend yield of 1.38%.
What the numbers say
CleaRank Financial AI's reading of ALLE's valuation, growth and risks.
ALLE's trailing P/E stands at 20.52, which puts it 39.7% under the Industrials median of 34.0. The peer comparison on this page labels that gap a discount to peers. On sales, the stock trades at 3.10 times, 22.5% below the sector median of 4.0.
ALLE is growing revenue at 12.70%, which is 1.0 percentage points faster than the sector median of 11.7%. Sales turn into profit at a net margin of 15.36% and an operating margin of 22.10%. Return on equity stands at 33.73%, above the sector median of 17.8%. On the balance sheet, debt-to-equity is 1.05, and the trailing dividend yield is 1.38%, or $2.16 a share a year.
EPS of $2.40 against an estimate of $2.22 made the July 23, 2026 report a beat of 8.11%. The market reacted the other way, with the stock falling 0.78% the following session.
Over its last 7 reports, ALLE topped the estimate 6 times, but beats have not guaranteed gains: the stock fell the next day after 4 of them. Looking ahead, analysts expect EPS of $8.96 this fiscal year (growth of 10.0%) and $9.78 the year after (growth of 9.2%).
Allegion's average daily move is 1.40%. Over the last 18 months, insiders disposed of $5.2M in stock while buying $591K. Sales like these are frequently scheduled ahead of time, so they carry less weight than purchases do.
ALLE against the Industrials sector
How ALLE compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: ALLE trades at a notable discount to sector peers (-40%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 6, 2025, ALLE has gained 11.9% against a gain of 25.6% for XLI.
Performance against XLI
ALLE and the Industrials sector fund over the same days.
Revenue and earnings
How much ALLE sells, and how much of it becomes profit.
Revenue growth: Revenue grew 7.8% in FY2025 to $4.1B, from $3.8B a year earlier.
Profit margin: The net margin was 15.8% in FY2025, down from 15.8% the year before.
Profitable: ALLE earned $644M in FY2025.
Earnings reality check
Did ALLE beat what analysts expected, and how did the stock react?
Earnings record: ALLE beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 23, 2026after close | $2.22 | $2.40 | +8.11% | -0.78% | +1.61% |
| Apr 28, 2026after close | $1.90 | $1.80 | -5.26% | -0.36% | -4.04% |
| Oct 23, 2025after close | $2.24 | $2.30 | +2.68% | -2.29% | -3.46% |
| Jul 24, 2025after close | $1.99 | $2.04 | +2.51% | +1.05% | +1.37% |
| Apr 24, 2025after close | $1.67 | $1.86 | +11.38% | -2.16% | -0.59% |
| Feb 18, 2025after close | $1.75 | $1.86 | +6.29% | +0.55% | +3.18% |
| Oct 24, 2024after close | $1.98 | $2.16 | +9.09% | -1.84% | -3.88% |
As of October 17, 2026, ALLE has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on July 23, 2026, came in 8.11% above the estimate and the stock moved -0.78% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 56.5, in neutral territory.RSI above 50 ›
An RSI of 56.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of ALLE
The score, the reasoning behind it, and what could move the price next.
Allegion (ALLE) shows a mixed trend. The stock, priced at $156.54, sits 0.04% below its 50-day average of $156.60, yet it is 4.44% above its 200-day average of $149.88. The 50-day average is 4.49% above the 200-day, but the price has dropped beneath the shorter average. Across its 52-week range of $125.00 to $183.11, the price stands at 54%, and it is 14.51% below the high.
Recent gains are set against a weaker longer-term record. The price is up 2.44% over the past month and up 14.06% over three months, yet it is down 11.81% over the past year. Momentum sits in neutral territory, with the 14-day RSI at 56.5 in the neutral zone and the MACD line negative.
Analyst upgrade ›
Longbow Research upgraded it to Buy from Neutral on June 11, 2026.
Source: Analyst action, Longbow Research, June 11, 2026Rating reaffirmed ›
Morgan Stanley kept its Equal-Weight rating on August 10, 2026.
Source: Analyst action, Morgan Stanley, August 10, 2026
Earnings beat ›
The July 23, 2026 report beat the EPS estimate by 8.11%, and the share price fell 0.78% in the first session after it.
Source: Earnings report, July 23, 2026
- The two closest levels to keep an eye on are the 52-week high at $183.11, which lies above the price, and the 20-day EMA at $153.51, which lies below it.
- The 14-day RSI reads 56.5, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price dropped 0.78% in the first session after the July 23, 2026 report. Across the last 7 reports, ALLE has beaten estimates 6 times.
ALLE is trading right at the 50-day SMA. The trend is mixed: ALLE is above its 200-day average at $149.88 but below its 50-day average at $156.60. A close above the 50-day would turn both signals up, and a close below the 200-day would turn both down. The next levels are the 20-day EMA at $153.51 below and the 52-week high at $183.11 above.
Technical indicators
Momentum and trend for ALLE, from its daily closes.
As of October 17, 2026, with ALLE at $156.54, its 14-day RSI is 56.5 (neutral territory), its 50-day simple moving average is $156.60 and its 200-day is $149.88.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ALLE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, ALLE's 1-year correlation of daily returns is +0.38 with S&P 500 (SPY), +0.27 with Nasdaq 100 (QQQ), +0.06 with Bitcoin (BTC) and +0.14 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
6 of 11 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $170.00 is 8.6% above the price.More buy ratings than three months ago ›
6 of 11 rate it a buy now, against 4 of 11 three months ago.
ALLE Wall Street View
12-month price targets
The price, $156.54, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 10, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Jul 24, 2026 | JP Morgan | Maintains | Neutral |
| Jul 24, 2026 | B of A Securities | Maintains | Neutral |
| Jul 24, 2026 | Baird | Maintains | Neutral |
| Jun 11, 2026 | Longbow Research | Upgrade | Buy |
| Jun 3, 2026 | Morgan Stanley | Maintains | Equal-Weight |
As of October 17, 2026, 11 Wall Street analysts cover ALLE: 6 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $160.00 to $202.00, with a median of $170.00, 8.6% above the price of $156.54.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ALLE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from ALLE's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ALLE tends to move, against the market and on its own.
The long record
ALLE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.40% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 38.9%, from February 2020 to April 2020, regained by April 2021.Most 1-year holds ended higher ›
69% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $25,790, against $42,055 in the S&P 500 (SPY).
ALLE Drawdowns & Recovery
As of October 17, 2026, ALLE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -38.9% (February 2020 to April 2020); it regained that peak by April 2021, 12 months after the low, and 69% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ALLE in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: ALLE trailed the S&P 500 over this period: $25,790 against $42,055.
A $10,000 investment in ALLE in October 2016 would be worth about $25,790 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ALLE, and which have not.
Strongest month, November: an average of +5.54%, up in 9 of 10 years.
Weakest month, March: an average of -1.65%, up in 5 of 10 years.
This month, October: has averaged -0.58%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, ALLE's strongest calendar month has been November (average +5.54%, up in 9 of 10 years) and its weakest March (average -1.65%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ALLE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ALLE today could grow to about $20,138 by 2036 in the base case, with a 90th-percentile outcome near $60,618 and a 10th-percentile outcome around $6,690. The simulation models price only; at today's 1.38% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
ALLE Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $207 for ALLE by 2030 in the base case, from $157 today (1.3x over 4 years). The 10th-percentile path ends near $103. These are outcomes of a Monte Carlo simulation run on ALLE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $118 | $168 | $238 | |
| 2028 | $110 | $180 | $295 | |
| 2029 | $106 | $193 | $353 | |
| 2030 | $103 | $207 | $416 | |
| 2031 | $102 | $222 | $484 |
Method: a lognormal simulation of ALLE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
ALLE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $591K on the open market and sold $5.2M.
As of October 17, 2026, ALLE insiders reported 10 open-market sales worth $5.2M and 3 open-market purchases worth $591K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Steven Mizell
Director
|
Buy | 170 | $26.9K |
| Aug 19, 2026 | Timothy P Eckersley
Officer
|
Grant | 1.5K | - |
| Aug 18, 2026 | David S. Ilardi
Officer
|
Sell | 549 | $88.4K |
| Aug 18, 2026 | David S. Ilardi
Officer
|
Option | 549 | $39.4K |
| Aug 6, 2026 | Vincent Wenos
Officer
|
Sell | 1.0K | $168.3K |
| Jul 27, 2026 | Timothy P Eckersley
Officer
|
Sell | 6.4K | $1.0M |
| Jul 23, 2026 | Michael J. Wagnes
Chief Financial Officer
|
Sell | 3.2K | $480.7K |
| Jul 23, 2026 | Nickolas A. Musial
Officer
|
Sell | 687 | $106.5K |
| Jul 23, 2026 | Nickolas A. Musial
Officer
|
Option | 687 | $49.4K |
| Jul 23, 2026 | Michael J. Wagnes
Chief Financial Officer
|
Option | 3.2K | $250.9K |
| Jun 4, 2026 | Susan L Main
Director
|
Grant | 1.1K | - |
| Jun 4, 2026 | Steven Mizell
Director
|
Grant | 1.1K | - |
| Jun 4, 2026 | Haughey Nicole Parent
Director
|
Grant | 1.1K | - |
| Jun 4, 2026 | Lauren B Peters
Director
|
Grant | 1.6K | - |
| Jun 4, 2026 | Ellen Rubin
Director
|
Grant | 1.1K | - |
| Jun 4, 2026 | Gregg C Sengstack
Director
|
Grant | 1.1K | - |
| Jun 4, 2026 | Dev Vardhan
Director
|
Grant | 1.1K | - |
| May 7, 2026 | Robert C Martens
Officer
|
Sell | 4.0K | $547.6K |
| Mar 11, 2026 | Susan L Main
Director
|
Buy | 2.0K | $299.2K |
| Feb 19, 2026 | Steven Mizell
Director
|
Sell | 1.4K | $227.0K |
| Feb 19, 2026 | Joseph Blasko
General Counsel
|
Grant | 1.4K | - |
| Feb 19, 2026 | Timothy P Eckersley
Officer
|
Grant | 1.7K | - |
| Feb 19, 2026 | Jennifer L Hawes
Officer
|
Grant | 1.1K | - |
| Feb 19, 2026 | David S. Ilardi
Officer
|
Grant | 1.7K | - |
| Feb 19, 2026 | Tracy L Kemp
Chief Technology Officer
|
Grant | 923 | - |
| Feb 19, 2026 | Robert C Martens
Officer
|
Grant | 1.1K | - |
| Feb 19, 2026 | Nickolas A. Musial
Officer
|
Grant | 923 | - |
| Feb 19, 2026 | John H Stone
Chief Executive Officer
|
Grant | 10.1K | - |
| Feb 19, 2026 | Michael J. Wagnes
Chief Financial Officer
|
Grant | 2.5K | - |
| Feb 19, 2026 | Vincent Wenos
Chief Technology Officer
|
Grant | 999 | - |
| Feb 4, 2026 | Timothy P Eckersley
Officer
|
Grant | 7.3K | - |
| Feb 4, 2026 | David S. Ilardi
Officer
|
Grant | 4.1K | - |
| Feb 4, 2026 | Tracy L Kemp
Chief Technology Officer
|
Grant | 2.8K | - |
| Feb 4, 2026 | Robert C Martens
Officer
|
Grant | 3.1K | - |
| Feb 4, 2026 | Nickolas A. Musial
Officer
|
Grant | 557 | - |
| Feb 4, 2026 | John H Stone
Chief Executive Officer
|
Grant | 30.5K | - |
| Feb 4, 2026 | Michael J. Wagnes
Chief Financial Officer
|
Grant | 8.3K | - |
| Feb 4, 2026 | Vincent Wenos
Chief Technology Officer
|
Grant | 2.8K | - |
| Nov 25, 2025 | Lauren B Peters
Director
|
Buy | 1.6K | $264.7K |
| Aug 7, 2025 | Timothy P Eckersley
Officer
|
Sell | 10.8K | $1.8M |
| Jul 25, 2025 | Tracy L Kemp
Chief Technology Officer
|
Sell | 3.8K | $634.8K |
| Jul 25, 2025 | Tracy L Kemp
Chief Technology Officer
|
Option | 2.3K | $204.2K |
| Jul 2, 2025 | Joseph Blasko
General Counsel
|
Grant | 1.5K | - |
| Jun 5, 2025 | Susan L Main
Director
|
Grant | 1.0K | - |
| Jun 5, 2025 | Steven Craig Mizell
Director
|
Grant | 1.0K | - |
| Jun 5, 2025 | Haughey Nicole Parent
Director
|
Grant | 1.0K | - |
| Jun 5, 2025 | Lauren B Peters
Director
|
Grant | 1.6K | - |
| Jun 5, 2025 | Ellen Rubin
Director
|
Grant | 1.0K | - |
| Jun 5, 2025 | Gregg C Sengstack
Director
|
Grant | 1.0K | - |
| Jun 5, 2025 | Dev Vardhan
Director
|
Grant | 1.0K | - |
| May 9, 2025 | Vincent Wenos
Chief Technology Officer
|
Sell | 961 | $136.3K |
| May 9, 2025 | Vincent Wenos
Chief Technology Officer
|
Option | 961 | $69.0K |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.